JP2000126197A - Ultrasonic therapeutic apparatus - Google Patents

Ultrasonic therapeutic apparatus

Info

Publication number
JP2000126197A
JP2000126197A JP10304080A JP30408098A JP2000126197A JP 2000126197 A JP2000126197 A JP 2000126197A JP 10304080 A JP10304080 A JP 10304080A JP 30408098 A JP30408098 A JP 30408098A JP 2000126197 A JP2000126197 A JP 2000126197A
Authority
JP
Japan
Prior art keywords
ultrasonic
condition
irradiation
focus
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP10304080A
Other languages
Japanese (ja)
Other versions
JP4091179B2 (en
Inventor
Katsuhiko Fujimoto
克彦 藤本
Satoshi Aida
聡 相田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toshiba Corp
Original Assignee
Toshiba Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toshiba Corp filed Critical Toshiba Corp
Priority to JP30408098A priority Critical patent/JP4091179B2/en
Priority to US09/425,986 priority patent/US6540700B1/en
Publication of JP2000126197A publication Critical patent/JP2000126197A/en
Priority to US10/361,919 priority patent/US20030149380A1/en
Application granted granted Critical
Publication of JP4091179B2 publication Critical patent/JP4091179B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

PROBLEM TO BE SOLVED: To realize the optimum irradiation so as not to damage a caution area by specifying a positional relationship between the positions of an ultrasonic focus and a caution area to determine making power and irradiation time according to a function of an intensity value at the p positions of the ultrasonic focus and the caution area as given based on the positional relationship. SOLUTION: In the treatment, an applicator is placed on a patient 3 laid on the side and a coupling film 5 thereof is kept in contact with a body surface 6 through an ultrasonic gel or the like. Then, a tomographic image containing an affected part 7 is reconstructed by an ultrasonic diagnostic instrument 16 based on a reflected wave signal from the patient 3 obtained by an ultrasonic probe 15 and the position of an ultrasonic focus 8 of a piezoelectric element 2 is displayed on a CRT 18 in superimposition on the reconstructed image through a DSC 17 to adjust the applicator for positioning, Thereafter, the position of the body surface of the patient and other positions of caution areas are specified to determine the making power and irradiation time according to a function of intensity values at the focus position and the caution area positions based on the positions thereby controlling the excitation of the piezoelectric element 2.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、超音波を使用して
生体内の腫瘍などを治療する超音波治療装置に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an ultrasonic treatment apparatus for treating a tumor or the like in a living body using ultrasonic waves.

【0002】[0002]

【従来の技術】近年、MIT(Minimally I
nvasive Treatment)とよばれる最少
侵襲治療の流れが医療の各分野で注目を集めている。一
例としては、結石症の治療に体外から強力超音波を照射
し、無侵襲的に結石を破砕治療する結石破砕装置の実用
化が挙げられ、泌尿器系結石の治療法を大きく様変わり
させた。
2. Description of the Related Art In recent years, MIT (Minimally I
The flow of minimally invasive treatment called nvasive treatment has attracted attention in various medical fields. One example is the practical use of a calculus crushing device that irradiates intense ultrasonic waves from outside the body to treat calculus and non-invasively crushes and treats calculus. This has greatly changed the method of treating urinary calculus.

【0003】この結石破砕装置に使用される強力超音波
発生源の方式には、水中放電方式、電磁誘導方式、微小
爆発方式。ピエゾ方式等がある。特にピエゾ方式強力超
音波発生源を用いた装置では、強力超音波の圧力は小さ
いという短所があるものの、小焦点であり且つ消耗品が
なくして強力超音波圧力を任意にコントロールできるこ
と、及び、複数のピエゾ素子に印加する駆動電圧を位相
制御することで焦点位置を任意にコントロールできるこ
と等、優れた長所がある(特開昭60−145131号
公報、米国特許明細書第4526168号)。
[0003] As a system of a powerful ultrasonic generator used in this calculus breaking device, there are an underwater discharge system, an electromagnetic induction system and a micro explosion system. Piezo method and the like are available. In particular, in a device using a piezo-type high-intensity ultrasonic wave source, although the pressure of the high-intensity ultrasonic wave is low, the high-intensity ultrasonic pressure can be arbitrarily controlled with a small focus and no consumables. There is an excellent advantage that the focus position can be arbitrarily controlled by controlling the phase of the driving voltage applied to the piezo element (JP-A-60-145131, US Pat. No. 4,526,168).

【0004】また、特に悪性新生物、いわゆる癌の場合
には、その治療の多くを外科的手法に頼っている現状か
ら、本来その臓器が持つ機能や外見上の形態を大きく損
なう場合が極めて多い。このため、生命を長らえたとし
ても患者にとって大きな負担が残ることから、QOL
(Quality Of Life)を考慮したより低
侵襲な治療法(装置)の開発が強く望まれている。
[0004] In particular, in the case of malignant neoplasms, so-called cancers, since most of the treatments rely on surgical techniques, the functions and appearance of the organs are extremely greatly impaired in many cases. . For this reason, even if the life is prolonged, a large burden remains on the patient.
There is a strong demand for the development of a less invasive treatment method (apparatus) in consideration of (Quality Of Life).

【0005】従来、手術、放射線療法及び化学療法(抗
癌剤)が癌の3大療法であるが、上述のような低侵襲治
療の流れの中で、新しい癌治療技術の1つとして熱を利
用した治療法が注目を浴びるようになってきた。その著
名な例がハイパーサーミア治療である。
Conventionally, surgery, radiation therapy and chemotherapy (anticancer drugs) are the three major therapies for cancer. In the course of the above-mentioned minimally invasive treatment, heat has been used as one of new cancer treatment techniques. Treatments have come to the fore. A prominent example is hyperthermia treatment.

【0006】ハイパーサーミア治療は、腫瘍組織と正常
組織の熱感受性の違いを利用して、患部を42.5〜4
3℃以上に加温及び維持することで、癌細胞のみを選択
的に死滅させる治療法である。
[0006] Hyperthermia treatment uses the difference in the thermal sensitivity between tumor tissue and normal tissue to cure the affected area between 42.5 and 42.5.
This is a treatment method in which only cancer cells are selectively killed by heating and maintaining the temperature at 3 ° C. or higher.

【0007】加温の方法としては、マイクロ波等の電磁
波を用いる方法が先行しているが、この方法では生体の
電気的特性により深部の腫瘍を選択的に加温することは
困難であり、深さ5cm以上の腫瘍に対しては良好な治
療成績は望めない。
As a method of heating, a method using an electromagnetic wave such as a microwave has been preceded, but it is difficult to selectively heat a deep tumor by this method due to the electrical characteristics of a living body. Good results cannot be expected for tumors with a depth of 5 cm or more.

【0008】また近年、電磁波エネルギーの深達性の悪
さを改善するためにマイクロ波/RF波アンテナを術中
及び腹腔鏡下又は経皮的に患部に刺入し、アンテナ周辺
の温度を60℃以上に加熱することで、局所的な治療効
果を向上させた新しい治療法が脚光を浴びている(礒田
他:J.Microwave Surgery)。
In recent years, a microwave / RF wave antenna has been inserted into a diseased part intraoperatively or laparoscopically or percutaneously in order to improve the inaccessibility of electromagnetic wave energy, and the temperature around the antenna has been increased to 60 ° C. or more. A new therapeutic method that has improved the local therapeutic effect by heating at a high temperature has been spotlighted (Isota et al .: J. Microwave Surgery).

【0009】しかし、この治療法も臓器への穿刺を要す
るため、従来の手術療法よりは低侵襲であるが、穿刺に
伴う出血や播種(転移)等の副作用があるといった問題
点もある。
[0009] However, since this treatment also requires puncture of an organ, it is less invasive than conventional surgical treatment, but also has a problem that puncture has side effects such as bleeding and dissemination (metastasis).

【0010】これら従来法の問題点を解決すべく、エネ
ルギーの集束性が良く、且つ、深達度が高い超音波エネ
ルギーを利用して深部腫瘍を体外から加熱治療する方法
が提案されている(特開昭61−13955号公報)。
In order to solve the problems of these conventional methods, a method has been proposed in which a deep tumor is heat-treated from outside the body by using ultrasonic energy having a good energy focusing property and a high degree of penetration (see, for example, Japanese Patent Application Laid-Open No. H11-157556). JP-A-61-13955).

【0011】また、前述の加温治療法を更に進めて、ピ
エゾ素子より発生した超音波を患部に鋭く集束させて腫
瘍部分を80℃以上に加熱し、腫瘍組織を瞬時に熱変性
懐死させるような治療法も考えられている(G.Val
lancien et.al:Progress in
Urol.1991,1,84−88、米国特許明細
書5150711号)。
Further, the above-mentioned heating treatment method is further advanced, and the ultrasonic wave generated by the piezo element is sharply focused on the affected part to heat the tumor part to 80 ° C. or more, and the tumor tissue is instantaneously thermally denatured and necrotic. Such treatments are also being considered (G. Val)
lancien et. al: Progress in
Urol. 1991, 1, 84-88, U.S. Pat. No. 5,150,711).

【0012】この治療法では、従来のハイパーサーミア
とは異なり、焦点近傍の限局した領域に非常に強い強度
(数百〜数千W/cm2 )の超音波が投入されるため、
焦点近傍の狭い領域のみが瞬時に熱変性懐死させられ
る。
In this treatment method, unlike conventional hyperthermia, an ultrasonic wave of very high intensity (several hundreds to several thousand W / cm 2 ) is applied to a localized area near the focal point.
Only a small area near the focal point is instantaneously heat denatured and moribund.

【0013】しかし、小さな焦点をスキャンしながら患
部領域全体を焼灼する必要があるため、焦点の正確な位
置決めが非常に重要となると考えられる。これに関する
一つの解決法として、既に特開平5−253192号公
報にて、MRIの化学シフトを利用した体内非侵襲感度
分布画像化により術中の発熱点を計測する技術が知られ
ている。
However, since it is necessary to cauterize the entire affected area while scanning a small focus, accurate positioning of the focus is considered to be very important. As one solution to this, Japanese Patent Application Laid-Open No. 5-253192 has already known a technique of measuring an intraoperative non-invasive sensitivity distribution image using an MRI chemical shift to measure an intraoperative heating point.

【0014】更に、超音波単独のシステムでも、特許第
1851304号、特許第1821772号、特許第1
765452号のものにおいては、治療用超音波の焦点
領域からの反射波を検出して超音波画像上に表示する手
法について開示している。
Further, even in a system using only an ultrasonic wave, Japanese Patent No. 1851304, Japanese Patent No. 1821772, Japanese Patent No.
No. 765452 discloses a method of detecting a reflected wave of a therapeutic ultrasonic wave from a focal region and displaying the detected ultrasonic wave on an ultrasonic image.

【0015】[0015]

【発明が解決しようとする課題】以上のように、従来の
超音波治療装置では、非常に鋭く焦点が絞られ、超音波
エネルギーが強く集中するために、焦点領域では必要以
上の超音波強度即ち発熱が発生するという問題点があっ
た。
As described above, in the conventional ultrasonic therapy apparatus, since the focus is very sharply focused and the ultrasonic energy is strongly concentrated, the ultrasonic intensity more than necessary in the focal area, that is, There is a problem that heat is generated.

【0016】また、照射時間を考慮せずに焦点領域の超
音波強度を低下させると、全体の治療時間が増加し、治
療として非現実的になるという問題点があった。本発明
の目的は、焦点組織に所望の熱変性を惹起し且つ注意領
域を損傷させない最適な照射を実現できる、安全性の高
い超音波治療装置を提供することにある。
If the intensity of the ultrasonic wave in the focal region is reduced without taking the irradiation time into consideration, there is a problem that the entire treatment time increases and the treatment becomes unrealistic. SUMMARY OF THE INVENTION It is an object of the present invention to provide a highly safe ultrasonic therapy apparatus capable of inducing a desired thermal denaturation in a focal tissue and realizing an optimum irradiation without damaging an attention area.

【0017】[0017]

【課題を解決するための手段】上記課題を解決するため
に、本発明は、超音波発生源から照射された超音波を被
検体治療部位に集束させて治療を行う超音波治療装置に
おいて、超音波焦点位置と注意領域位置との位置関係を
与える手段と、この位置関係に基づき与えられる該超音
波焦点位置及び注意領域位置での強度値の関数に従っ
て、投入電力及び照射時間を決定する照射条件決定手段
とを具備することを特徴とする。
SUMMARY OF THE INVENTION In order to solve the above-mentioned problems, the present invention provides an ultrasonic treatment apparatus which focuses an ultrasonic wave emitted from an ultrasonic wave source on a treatment site of a subject to perform treatment. Means for giving a positional relationship between the sound wave focal position and the attention area position, and irradiation conditions for determining the applied power and the irradiation time according to a function of the intensity values at the ultrasonic focus position and the attention area position given based on the positional relation. Determining means.

【0018】また、前記照射条件決定手段は、前記焦点
変性条件及び注意領域非変性条件を予めメモリ上に保存
し、該メモリからデータを呼び出すことにより前記照射
条件を算出し及び決定することを特徴とする。
The irradiating condition determining means may store the defocusing condition and the attention area non-denaturing condition in a memory in advance, and calculate and determine the irradiating condition by retrieving data from the memory. And

【0019】さらに、本発明は、治療に先立って焦点変
性条件及び注意領域非変性条件を算出して保存する手段
を具備し、該保存した焦点変性条件及び注意領域非変性
条件に基づき治療の際の前記照射条件を算出し及び決定
することを特徴とする。
The present invention further comprises means for calculating and storing the defocusing condition and the attention area non-denaturing condition prior to the treatment, so that the treatment can be performed based on the stored focus degeneration condition and the attention area non-denaturing condition. Is calculated and determined.

【0020】またさらに、前記設定された投入電力及び
照射時間に対する必要インターバル時間を算出する手段
を更に具備することを特徴とする。本発明における超音
波治療装置では、照射条件として、焦点組織に所望の熱
変性を惹起し且つ注意領域を損傷させないことが求めら
れるところ、本発明によれば、照射時間を考慮した最適
な超音波強度での照射が実現できるため、必要以上の焦
点強度による副作用等の無く且つ治療時間内で最大限の
効果を上げられる、安全であり且つ効率的な照射治療を
実現できる。
Further, the apparatus is further characterized by further comprising means for calculating a required interval time for the set input power and irradiation time. In the ultrasonic therapy apparatus according to the present invention, as irradiation conditions, it is required to cause a desired thermal denaturation in the focal tissue and not to damage the attention area. According to the present invention, the optimum ultrasonic wave considering the irradiation time is required. Since irradiation with high intensity can be realized, safe and efficient irradiation treatment can be realized without any side effects or the like due to excessive focus intensity and the maximum effect can be achieved within the treatment time.

【0021】[0021]

【発明の実施の形態】以下、本発明の実施の形態を図面
に基づいて説明する。図1は本発明にかかる超音波治療
装置の一実施形態の構成を示すブロック図である。図1
に示すように、アプリケータ1は、強力超音波を発生す
るピエゾ素子2、強力超音波を患者3に導くカップリン
グ液4、カップリング膜5及び体内の断層画像を取得す
る超音波プローブ16より構成される。ピエゾ素子2
は、治療用強力超音波を照射する1つ又は複数の素子か
らなる。
Embodiments of the present invention will be described below with reference to the drawings. FIG. 1 is a block diagram showing the configuration of an embodiment of the ultrasonic therapy apparatus according to the present invention. FIG.
As shown in FIG. 1, the applicator 1 includes a piezo element 2 for generating high-intensity ultrasonic waves, a coupling liquid 4 for guiding high-intensity ultrasonic waves to a patient 3, a coupling film 5, and an ultrasonic probe 16 for acquiring a tomographic image of a body. Be composed. Piezo element 2
Consists of one or more elements that emit intense therapeutic ultrasound.

【0022】治療時には、まず患者3を図示しない餓死
しない寝台に乗せて所定位置に固定する。そしてアプリ
ケータ1を患者3体表に載せ、且つカップリング膜5を
図示しない超音波ゼリー等を使用して体表6に接触させ
る。
At the time of treatment, the patient 3 is first placed on a bed (not shown) that does not starve and fixed at a predetermined position. Then, the applicator 1 is placed on the body surface of the three patients, and the coupling film 5 is brought into contact with the body surface 6 using an ultrasonic jelly (not shown) or the like.

【0023】位置決めの際には、アプリケータ1中央に
挿入された超音波プローブ15により取得した患者3か
らの反射波信号をもとに超音波診断装置16によって患
部(腫瘍)7を含む断層像を再構成し、その再構成画像
上にピエゾ素子2の超音波焦点8の位置をDSC17を
介してCRT18上に重ねて表示する。
At the time of positioning, a tomographic image including an affected part (tumor) 7 is obtained by an ultrasonic diagnostic apparatus 16 based on a reflected wave signal from the patient 3 acquired by an ultrasonic probe 15 inserted into the center of the applicator 1. And the position of the ultrasonic focus 8 of the piezo element 2 is displayed on the CRT 18 via the DSC 17 on the reconstructed image.

【0024】この画像上の焦点位置と患者3体内患部
(腫瘍)7とを一致させるように、システムコントロー
ラ9からの信号によりステージコントローラ19に命令
を出し、該指示に従ってアプリケータ1を移動させるべ
くステージ20及びアーム21を制御し、位置決めを行
う。
An instruction is issued to the stage controller 19 by a signal from the system controller 9 so that the focal position on the image and the affected part (tumor) 7 in the patient 3 are matched, and the applicator 1 is moved in accordance with the instruction. The stage 20 and the arm 21 are controlled to perform positioning.

【0025】本実施形態では、図2に示すように、前記
位置決めを完了した後に、コンソールパネル10上で患
者体表位置他の注意領域の位置(照射に際して発熱等を
起こしやすい危険領域の位置)を指定し(ステップS
1)、該指定位置と焦点8位置との相対位置関係より、
最適な照射条件設定をメモリ11上より読み出し(ステ
ップS2)、システムコントローラ9の指示のもと、ア
プリケータ1の移動及び照射制御を行う(ステップS
3)。
In the present embodiment, as shown in FIG. 2, after the positioning is completed, the position of the attention area other than the surface of the patient on the console panel 10 (the position of the danger area where heat is likely to be generated upon irradiation). (Step S
1) From the relative positional relationship between the designated position and the focal point 8 position,
The optimum irradiation condition setting is read from the memory 11 (step S2), and the movement and irradiation control of the applicator 1 are performed under the instruction of the system controller 9 (step S2).
3).

【0026】ここで、照射制御は、メモリ11に記憶さ
れている投入電力及び照射時間及びインターバル設定に
従って、波形発生回路12を駆動し、その信号をRFア
ンプ13にて増幅し、マッチング回路14を介してピエ
ゾ素子2を励振することで行う。
Here, in the irradiation control, the waveform generating circuit 12 is driven in accordance with the input power, irradiation time and interval setting stored in the memory 11, the signal is amplified by the RF amplifier 13, and the matching circuit 14 is controlled. This is performed by exciting the piezo element 2 via the piezoelectric element.

【0027】前記実施形態では、超音波通過経路の注意
領域の指定を、操作者によるコンソールパネル10から
の入力情報に従って行ったが、例えば、体表等の位置は
通過領域の一定輝度以上のハイエコー領域を画像処理及
び自動抽出することで当該注意領域の指定を行ってもよ
い。
In the above-described embodiment, the attention area of the ultrasonic wave passage is specified in accordance with the input information from the console panel 10 by the operator. The attention area may be designated by image processing and automatic extraction of the area.

【0028】また、体表位置は、図示しないプローブ突
出量エンコーダからのプローブ体表接触時の突出量情報
より、取得及び算出してもよい。更には、アプリケータ
1の接触位置の一般的は解剖学的位置関係より、治療深
さの指定又は自動検出のみで照射条件を既定値として設
定してもよい。
The body surface position may be obtained and calculated from protrusion amount information when a probe body contact is made from a probe protrusion amount encoder (not shown). Furthermore, the irradiation condition may be set as a default value only by specifying the treatment depth or by automatic detection only from the general anatomical positional relationship of the contact position of the applicator 1.

【0029】次に、図3に最適な照射条件設定のための
基礎となる特性図を示す。図3の(a )は焦点領域での
熱変性及び細胞破壊の閾値を示す特性図であり、図3の
(b)は超音波通過領域での注意領域組織の障害閾値を
示す特性図である。
Next, FIG. 3 shows a characteristic diagram serving as a basis for setting optimum irradiation conditions. FIG. 3A is a characteristic diagram showing a threshold value of thermal denaturation and cell destruction in a focal region, and FIG. 3B is a characteristic diagram showing a damage threshold value of an attention region tissue in an ultrasonic passage region. .

【0030】本実施形態では、注意領域に所望の熱変性
を惹起し且つ通過領域組織に損傷を起こさないために、
通過経路での減衰を考慮した焦点強度が最適変性条件範
囲内に入っており、且つ、超音波通過領域が非変性条件
内に入っている必要がある。各特性図の縦軸を減衰を考
慮して投入電力に読み替えることで、1回の照射で投入
可能な電力×照射時間の設定範囲として上限値及び下限
値が求まる。
In the present embodiment, in order to cause a desired heat denaturation in the attention area and not to damage the passage area tissue,
It is necessary that the focus intensity considering the attenuation in the passing path is within the optimum denaturing condition range, and that the ultrasonic wave transmitting region is within the non-denaturing condition. By replacing the vertical axis of each characteristic diagram with the input power in consideration of the attenuation, the upper limit value and the lower limit value are obtained as a setting range of “power input in one irradiation × irradiation time”.

【0031】以下、照射条件設定を図3及び図4を参照
して具体的に説明する。まず、患部7の位置と強力超音
波通過領域内の注意領域の位置の絶対/相対位置関係か
ら、ある投入電力値を設定したときの焦点強度IF1及び
注意領域での超音波強度IS1が算出する(ステップT
1)。これら焦点強度IF1及び超音波強度IS1の値を各
特性図上で横に伸ばすと、焦点及び注意領域での照射可
能時間(範囲)が求められる(ステップT2)。
Hereinafter, the setting of the irradiation conditions will be specifically described with reference to FIGS. First, the absolute / relative positional relationship between the position of the attention area in the position and power ultrasound passage area of the diseased part 7, the ultrasonic wave intensity I S1 of the focus intensity I F1 and attention region when setting the certain input power value Calculate (Step T
1). When extending the value of the focal intensity I F1, and ultrasonic intensity I S1 laterally on the diagram the characteristics, irradiation available time at the focus and attention area (range) is determined (step T2).

【0032】ここで、IF1及びIS1の値のAND条件を
取ると、焦点組織に所望の熱変性を惹起し、且つ、注意
領域を損傷させない照射時間条件が求まる(ステップT
3)。この場合、投入電力を上げると、IF1,IS1共に
投入電力に比例して上昇し、照射時間条件の解がなくな
る。
Here, if the AND conditions of the values of I F1 and I S1 are taken, the irradiation time condition which causes the desired thermal denaturation in the focal tissue and does not damage the attention area is obtained (step T).
3). In this case, if the applied power is increased, both I F1 and I S1 increase in proportion to the applied power, and there is no solution for the irradiation time condition.

【0033】逆に、投入電力を下げると、AND領域は
広がるが、照射時間が長くなり、実際の治療を考慮した
場合に現実的では無くなる。従って、実際の治療に際し
て実現的な照射時間限界を考慮すると、設定投入電力×
照射時間条件に上限値及び下限値が存在することが分か
り、該上限値及び下限値を求める(ステップT4)。
Conversely, when the applied power is reduced, the AND region is widened, but the irradiation time is lengthened, which is not practical when considering actual treatment. Therefore, considering the practical irradiation time limit in actual treatment, the set input power ×
It is found that the irradiation time condition has an upper limit and a lower limit, and the upper limit and the lower limit are obtained (step T4).

【0034】尚、照射設定はどの値でも構わないが、例
えば、1点での変性量をできるだけ多く確保するため
に、上限値を使用することとする。この設定方針を予め
決定しておけば、自動的に投入電力と照射時間を決定で
きる。該決定の下で、波形発生回路12を駆動し、アプ
リケータ1から強力超音波を発生する。
The irradiation setting may be any value, but, for example, an upper limit value is used in order to secure as much denaturation amount at one point as possible. If this setting policy is determined in advance, the applied power and the irradiation time can be automatically determined. Under the determination, the waveform generating circuit 12 is driven to generate strong ultrasonic waves from the applicator 1.

【0035】ここで、注意領域での変性−非変性閾値は
照射インターバル(時間)によって変動し、投入電力と
照射時間が決定されれば、インターバル時間が決定され
る。IF1とIS1の相互の関係は、音源の集束度と周波
数、焦点と注意領域との相対位置及び減衰との関係によ
り決定され、ある関数で示される。その関数を予めメモ
リ11上に有しており、その値に基づいてシステムコン
トローラ9により計算を行うことで、前記手順に従って
照射条件を決定できる。
Here, the denaturation-non-denaturation threshold in the attention area varies depending on the irradiation interval (time). If the input power and the irradiation time are determined, the interval time is determined. Mutual relationship of I F1 and I S1 is focused degree and frequency of the sound source is determined by the relationship between the relative position and the attenuation between the focus and attention region, represented by a function. The function is stored in the memory 11 in advance, and the irradiation condition can be determined according to the above procedure by performing calculation by the system controller 9 based on the value.

【0036】本発明は、上述した実施形態に限らない。
すなわち、先に述べた実施形態は、メモリ11に予め照
射条件が記憶されている例であったが、本実施形態で
は、ステップU1として、メモリ11に記憶すべき照射
条件を、治療の実行(ステップU2)に先立つ求めるも
のである。治療の実行の後は、ステップU3にて終了、
継続、照射条件の再設定となる。
The present invention is not limited to the above embodiment.
That is, the above-described embodiment is an example in which the irradiation condition is stored in the memory 11 in advance, but in the present embodiment, the irradiation condition to be stored in the memory 11 is determined in step U1 by executing the treatment ( This is to be determined prior to step U2). After the execution of the treatment, it ends in step U3,
Continue and reset the irradiation conditions.

【0037】また、先の実施形態では、設定範囲として
一つの上限値と一つの下限値を用いたが、図6に示すよ
うに、上限値・下限値選択器100をシステムコントロ
ーラ9に設けて、一つの上限値101と、複数の下限値
102a ,102b,102cとをスイッチ103によ
り、適宜選択して用いる構成としても良い。
In the above embodiment, one upper limit and one lower limit are used as the setting ranges. However, as shown in FIG. 6, an upper limit / lower limit selector 100 is provided in the system controller 9. Alternatively, one upper limit 101 and a plurality of lower limits 102a, 102b, 102c may be appropriately selected and used by the switch 103.

【0038】[0038]

【発明の効果】以上説明したように本発明によれば、照
射時間を考慮した最適な超音波強度での照射が実現でき
るため、必要以上の焦点強度による副作用等が無く且つ
治療時間内で最大限の効果を上げられる、安全且つ効率
的な照射治療を実現できる超音波治療装置を提供できる
ものである。
As described above, according to the present invention, it is possible to realize irradiation with an optimum ultrasonic intensity in consideration of the irradiation time, so that there is no side effect due to unnecessary focus intensity and the maximum within the treatment time. It is an object of the present invention to provide an ultrasonic therapy apparatus capable of realizing safe and efficient radiation therapy with a limited effect.

【図面の簡単な説明】[Brief description of the drawings]

【図1】本発明の第1の実施形態の構成を示すブロック
図。
FIG. 1 is a block diagram showing a configuration of a first embodiment of the present invention.

【図2】本発明の第1の実施形態の動作を示す流れ図。FIG. 2 is a flowchart showing the operation of the first embodiment of the present invention.

【図3】本発明の第1の実施形態における照射条件決定
のための境界条件を示す図。
FIG. 3 is a diagram showing boundary conditions for determining irradiation conditions according to the first embodiment of the present invention.

【図4】本発明の第1の実施形態における照射条件を設
定する動作を示す流れ図。
FIG. 4 is a flowchart showing an operation for setting irradiation conditions according to the first embodiment of the present invention.

【図5】本発明の他の実施形態の構成を示す流れ図。FIG. 5 is a flowchart showing the configuration of another embodiment of the present invention.

【図6】本発明の他の実施形態の構成を示すブロック
図。
FIG. 6 is a block diagram showing a configuration of another embodiment of the present invention.

【符号の説明】[Explanation of symbols]

1 … アプリケータ 2 … ピエゾ素子 3 … 患者 4 … カップリング液 5 … カップリング膜 6 … 体表 7 … 患部(腫瘍) 8 … 焦点 9 … システムコントローラ 10 … コンソールパネル 11 … メモリ 12 … 波形発生回路 13 … RFアンプ 14 … インピーダンスマッチング回路 15 … 超音波プローブ 16 … 超音波診断装置 17 … デジタルスキャンコンバータ(DSC) 18 … CRT 19 … ステージコントローラ 20 … ステージ 21 … アーム DESCRIPTION OF SYMBOLS 1 ... Applicator 2 ... Piezo element 3 ... Patient 4 ... Coupling liquid 5 ... Coupling film 6 ... Body surface 7 ... Affected part (tumor) 8 ... Focus 9 ... System controller 10 ... Console panel 11 ... Memory 12 ... Waveform generation circuit Reference Signs List 13 RF amplifier 14 Impedance matching circuit 15 Ultrasonic probe 16 Ultrasonic diagnostic device 17 Digital scan converter (DSC) 18 CRT 19 Stage controller 20 Stage 21 Arm

───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4C060 JJ25 JJ27 KK50 MM24 MM25 MM26 MM27 4C099 AA01 CA19 GA30 JA01 JA11 JA13 JA20 PA01 PA06  ──────────────────────────────────────────────────続 き Continued on the front page F term (reference) 4C060 JJ25 JJ27 KK50 MM24 MM25 MM26 MM27 4C099 AA01 CA19 GA30 JA01 JA11 JA13 JA20 PA01 PA06

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】超音波発生源から照射された超音波を被検
体治療部位に集束させて治療を行う超音波治療装置にお
いて、 超音波焦点位置と注意領域位置との位置関係を与える手
段と、 この位置関係に基づき与えられる該超音波焦点位置及び
注意領域位置での強度値の関数に従って、投入電力及び
照射時間を決定する照射条件決定手段とを具備すること
を特徴とする超音波治療装置。
1. An ultrasonic treatment apparatus for performing treatment by focusing an ultrasonic wave emitted from an ultrasonic wave source on an object treatment site, a means for giving a positional relationship between an ultrasonic focus position and an attention area position, An ultrasonic treatment apparatus comprising: irradiation condition determining means for determining an applied power and an irradiation time in accordance with a function of an intensity value at the ultrasonic focus position and the attention area position given based on the positional relationship.
【請求項2】前記照射条件決定手段は、前記焦点変性条
件及び注意領域非変性条件を予めメモリ上に保存し、該
メモリからデータを呼び出すことにより前記照射条件を
算出し及び決定することを特徴とする請求項1に記載の
超音波治療装置。
2. The irradiation condition determining means stores the focus degeneration condition and the attention area non-denaturation condition in a memory in advance, and calculates and determines the irradiation condition by calling data from the memory. The ultrasonic therapy apparatus according to claim 1, wherein
【請求項3】治療に先立って焦点変性条件及び注意領域
非変性条件を算出して保存する手段を具備し、該保存し
た焦点変性条件及び注意領域非変性条件に基づき治療の
際の前記照射条件を算出し及び決定することを特徴とす
る請求項1に記載の超音波治療装置。
3. A means for calculating and storing a focus degenerative condition and an attention area non-denaturing condition prior to treatment, wherein the irradiation condition at the time of treatment is based on the stored focus degenerate condition and attention area non-denaturation condition. The ultrasonic therapy apparatus according to claim 1, wherein the ultrasonic therapy apparatus calculates and determines the following.
【請求項4】前記設定された投入電力及び照射時間に対
する必要インターバル時間を算出する手段を更に具備す
ることを特徴とする請求項1乃至3のいずれか一項に記
載の超音波治療装置。
4. The ultrasonic treatment apparatus according to claim 1, further comprising a unit for calculating a required interval time for the set input power and irradiation time.
JP30408098A 1998-10-26 1998-10-26 Ultrasonic therapy device Expired - Fee Related JP4091179B2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP30408098A JP4091179B2 (en) 1998-10-26 1998-10-26 Ultrasonic therapy device
US09/425,986 US6540700B1 (en) 1998-10-26 1999-10-25 Ultrasound treatment apparatus
US10/361,919 US20030149380A1 (en) 1998-10-26 2003-02-11 Ultrasound treatment apparatus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP30408098A JP4091179B2 (en) 1998-10-26 1998-10-26 Ultrasonic therapy device

Publications (2)

Publication Number Publication Date
JP2000126197A true JP2000126197A (en) 2000-05-09
JP4091179B2 JP4091179B2 (en) 2008-05-28

Family

ID=17928796

Family Applications (1)

Application Number Title Priority Date Filing Date
JP30408098A Expired - Fee Related JP4091179B2 (en) 1998-10-26 1998-10-26 Ultrasonic therapy device

Country Status (1)

Country Link
JP (1) JP4091179B2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7806892B2 (en) 2001-05-29 2010-10-05 Ethicon Endo-Surgery, Inc. Tissue-retaining system for ultrasound medical treatment
RU2444061C2 (en) * 2005-07-08 2012-02-27 Пнн Медикал А/С Method of identifying element on two or more images
US9132287B2 (en) 2004-06-14 2015-09-15 T. Douglas Mast System and method for ultrasound treatment using grating lobes
US9261596B2 (en) 2001-05-29 2016-02-16 T. Douglas Mast Method for monitoring of medical treatment using pulse-echo ultrasound

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7806892B2 (en) 2001-05-29 2010-10-05 Ethicon Endo-Surgery, Inc. Tissue-retaining system for ultrasound medical treatment
US9005144B2 (en) 2001-05-29 2015-04-14 Michael H. Slayton Tissue-retaining systems for ultrasound medical treatment
US9261596B2 (en) 2001-05-29 2016-02-16 T. Douglas Mast Method for monitoring of medical treatment using pulse-echo ultrasound
US9132287B2 (en) 2004-06-14 2015-09-15 T. Douglas Mast System and method for ultrasound treatment using grating lobes
RU2444061C2 (en) * 2005-07-08 2012-02-27 Пнн Медикал А/С Method of identifying element on two or more images

Also Published As

Publication number Publication date
JP4091179B2 (en) 2008-05-28

Similar Documents

Publication Publication Date Title
US5643179A (en) Method and apparatus for ultrasonic medical treatment with optimum ultrasonic irradiation control
JP4686269B2 (en) Ultrasonic therapy device
RU2460489C2 (en) Based on image analysis connection for regulation of power for formation of optimal ultrasound image of radio-frequency tissue ablation
US6540700B1 (en) Ultrasound treatment apparatus
JP4322322B2 (en) Ultrasonic therapy device
JP4401354B2 (en) Ultrasonic therapy device
US9333026B2 (en) Radio frequency lasso
US20030018256A1 (en) Therapeutic ultrasound system
JP2001170068A (en) Ultrasonic treatment instrument
WO2008025190A1 (en) A high intensity focused ultrasound therapeutic system guided by an imaging device guided
JPH0747079A (en) Ultrasonic therapeutic system
KR20140008103A (en) A method and apparatus for generating a treatment plan to be provided to a focused ultrasound therapy apparatus
JP2006136441A (en) Apparatus and method for ultrasonic irradiation
Deardorff et al. Angular directivity of thermal coagulation using air-cooled direct-coupled interstitial ultrasound applicators
JP4091179B2 (en) Ultrasonic therapy device
JP2000237199A (en) Ultrasonic therapeutic device
JP2004097474A (en) Ultrasonic therapy apparatus
JPH11155894A (en) Ultrasonic medical treatment device and irradiation condition setting method
JP3764235B2 (en) Ultrasonic therapy device
RU2231991C2 (en) Method for treating unresectable primary and metastatic hepatic tumors
JP2006055403A (en) Treatment system, ultrasonic irradiation system and data management method in treatment system
JPH11226046A (en) Ultrasonic wave treatment device
Sanghvi et al. Microbubbles during tissue treatment using high intensity focused ultrasound
JP3142925B2 (en) Ultrasound therapy equipment
JP4286743B2 (en) Focused ultrasonic irradiation system

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20051018

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20071109

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071120

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080121

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20080226

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20080228

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110307

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120307

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130307

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140307

Year of fee payment: 6

LAPS Cancellation because of no payment of annual fees